Adicet Bio Announces Poster Presentation of ADI-270 Preclinical Data at the 2024 European Hematology Association (EHA) Hybrid Congress Published May 14, 2024 10:00am EDT ...

Biomea Fusion’s BMF-500 Selected for Poster Presentation at EHA 2025 Highlighting Phase I Data in Relapsed/Refractory Acute Leukemia Provided by GlobeNewswire May 14, 2025, 1:05:00 PM ...

Biomea Fusion presents preliminary Phase I clinical data for BMF-500 in treating relapsed acute leukemia at EHA 2025 Congress. Quiver AI Summary Biomea Fusion, Inc. has announced updated ...

Details of the poster presentation are as follows: Title: ADI-270: An Armored Allogeneic Anti-CD70 CAR γδ T Cell Therapy Designed for Multiple Solid and Hematological Cancer Indications ...

REDWOOD CITY, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (BMEA), a clinical-stage diabetes and obesity medicines company, today announced that preliminary clinical data from the ...